Yes, pharmaceutical companies are developing additional dual and triple agonist medications
Enhanced immune function It plays a role in supporting the immune system, enhancing your body's ability to protect against illnesses and infections
It may improve heart health in high-risk patients: The massive NEJM SELECT Analysis in 20232024 found that semaglutide reduced major cardiovascular events (heart attack, stroke, CV death) in people with overweight/obesity and established heart disease
So why isn't the fat moving faster
Common barriers include: Benefit exclusions: Your plan may not cover anti-obesity medications at all
Not as a beauty hack, but as a serious, science-backed tool for detox, resilience, and some much-needed restoration